All Canadian Prescriptions dispensed by

Newton Pharmacy
110 - 2626 Croydon Dr
Surrey, BC
Canada V3S 0S8
604-501-6963

Pharmacy Manager
Robert Lee
License Number 20928

Pharmacist available from
9am-4pm PST. Mon-Fri

No Manufacturer Listed

Luveris is the first and only recombinant human luteinizing hormone (r-hLH) approved in the world. Luveris is available in the U.S. for concomitant use with Gonal-f (follitropin alfa for injection) to stimulate follicular development in profoundly LH-deficient hypogonadotropic hypogonadal (HH) women (LH < 1.2 IU/L). A definitive effect on pregnancy in this population has been demonstrated. The safety and effectiveness of concomitant administration of Luveris with any other preparation of recombinant human FSH or urinary human FSH is unknown.

Your healthcare professional should review the risks and benefits of using Luveris® with you. As with any medication, report any and all side effects, symptoms or physical changes to your healthcare provider. Treatment with FSH and LH followed by human chorionic gonadotropin (hCG) can lead to a condition called ovarian hyperstimulation syndrome (OHSS). This condition can occur when the ovaries overreact to the treatment and become enlarged. A potential for the occurrence of blood clots in the blood vessels exists. Other conditions that can result from OHSS include blood volume changes or imbalances and extra fluid in the lungs or around the heart.